Address book
Contacts
MADDALENA MOGNATO
Position
Professoressa Associata
Structure
Address
VIA U. BASSI, 58/B - PADOVA
Telephone
0498276274
Associate professor of Cell Biology with a Ph.D in Environmental Medicine. Her research activity is focused on cytotoxic and genotoxic effects induced in human cells by ionizing (gamma/X rays, low energy protons), non-ionizing radiation(UV light, laser light), chemicals (nanoparticles, cisplatin, polycyclic aromatic hydrocarbons). She took part to projects funded by the Italian Space Agency to study the effects of ionizing radiation associated to modeled microgravity, focusing on DNA repair, in particular on that of double strand breaks. She collaborated at european projects to study the cytotoxic effects and the biocompatibility of different nanomaterials and to study the biological properties of nanosystems formuled to delivery drugs or other antineoplastic compounds. She collaborated with Istituto Oncologico Veneto (IOV) of Padova at the research on molecular biomarkers of individual radiosensitivity/radioresistance towards radiotherapy. Since several years she studies the role of microRNA (miRNAs) in the DDR pathway and their use as radiosensitizing agents for radioresistant human cancer cells.
Her research activity is documented in international paper with referee. She participated to many international and national conferences. She has been responsible of financial grants of Padova University.
Notices
Office hours
at Dipartimento di Biologia, V piano sud, stanza n.9
Ricevo su appuntamento concordato via mail
Teachings
- CELLS BIOLOGY, AA 2024 (SC06100878)
- HISTOLOGY, EMBRYOLOGY AND DEVELOPMENT, AA 2024 (SCP5071886)
- CELLS BIOLOGY, AA 2023 (SC06100878)
- HISTOLOGY, EMBRYOLOGY AND DEVELOPMENT, AA 2023 (SCP5071886)
- CELLS BIOLOGY, AA 2022 (SC06100878)
- HISTOLOGY, EMBRYOLOGY AND DEVELOPMENT, AA 2022 (SCP5071886)
- CELLS BIOLOGY, AA 2021 (SC06100878)
- HISTOLOGY, EMBRYOLOGY AND DEVELOPMENT, AA 2021 (SCP5071886)
- CELLS BIOLOGY, AA 2020 (SC06100878)
- CELLS BIOLOGY, AA 2019 (SC06100878)
- CELLS BIOLOGY, AA 2018 (SC06100878)
- CELLS BIOLOGY, AA 2017 (SC06100878)
- CELLS BIOLOGY, AA 2016 (SC06100878)
- CELLS BIOLOGY, AA 2015 (SC06100878)
- CELLS BIOLOGY, AA 2014 (SC06100878)
- CELLS BIOLOGY, AA 2013 (SC06100878)
- CELLS BIOLOGY, AA 2012 (SC06100878)
Research Area
•Study of the DNA-Damage Response to ionizing radiation of different qualities (gamma/X rays, low energy protons) in human primary cells and cancer cells.
•Analysis of gene and miRNA expression profiles in human cells exposed to genotoxic agents. Functional analysis of miRNA-mRNA interaction of DSB DNA repair.
•Identification of molecular biomarkers of individual radiosensitivity in oncological patients under radiotherapy.
•Nanotoxicology. Analysis of in vitro toxicity of differnt types of nanoparticles.
Thesis proposals
1. "Role of microRNAs in the DNA-Damage Response (DDR) to ionizing radiation ". MiRNAs are small non coding RNAs acting as post-transcriptional regulators of gene expression by binding to complementary 3’UTR of their target mRNA and causing mRNA translational repression or
destabilization and decay; as a consequence miRNAs reduce the expression of target genes.
DDR allows DNA damage detection, signal propagation and transduction to a multitude of effector proteins, which promote cell survival, activate cell cycle arrest to allow DNA repair, or apoptosis when cells are unable to properly repair DNA. DDR is regulated at both transcriptional and
post-transcriptional level. More than half of DDR genes contain conserved miRNA target
sites.
2. "Individual response to radiotherapy: identification of molecular biomarkers ".The study aims at defining a genetic signature of genes of the DNA Damage Response (DDR) pathway to define different degrees of patient radiosensitivity. Individual gene expression data from blood samples isolated from patients undergoing radiotherapy are integrated with clinical evaluation of tissue radio-sensitivity and with cytogenetic analyses in vitro. The research project is in collaboration with the Istituto Oncologico Veneto IOV-IRCCS (UOC of Radiotherapy), and with colleagues of the Dept. of Biology and Molecular Medicine of Padova University.